beta

APM

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/apm

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 57 trading days

From: 2018-12-24 To: 2019-03-19

Lowest Point:

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Stocks To Watch: Eyes On Boeing, Nvidia, Disney, Nike And WageWorks

via: SeekingAlpha at 2019-03-16 05:13:58:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Interest rates are back in the spotlight with a Federal Reserve interest rate decis… read more...

Aptorum Group (APM) Presents At Barclays Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2019-03-14 10:30:08:000

The following slide deck was published by Aptorum Group Limited in conjunction with this Read more … read more...

Aptorum Group (APM) Presents At Barclays Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2019-03-14 10:30:08:000

The following slide deck was published by Aptorum Group Limited in conjunction with this Read more … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX